{
  "abstract": "The controversial1 Alzheimer’s drug lecanemab has overcome another regulatory hurdle, with Australia’s drugs regulator approving the therapy after two rejections.2",
  "authors": [
    {
      "affiliations": [
        "Sydney"
      ],
      "name": "Bianca Nogrady"
    }
  ],
  "title": "Lecanemab: Controversial Alzheimer’s drug approved by Australian drugs regulator after two rejections",
  "uid": "0c191b05-1d6c-58b2-9c2a-02f71b541448"
}